BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31006778)

  • 1. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1].
    Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV
    Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of BRG1 (
    Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
    Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical teratoid/rhabdoid tumors of childhood].
    Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
    Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary diffuse leptomeningeal atypical teratoid/rhabdoid tumor diagnosed by cerebrospinal fluid cytology: case report with molecular genetic analysis.
    Tomomasa R; Nakata S; Nobusawa S; Horiguchi K; Matsumura N; Ikota H; Hirato J; Yoshimoto Y; Yokoo H
    Hum Pathol; 2018 Jul; 77():116-120. PubMed ID: 29339179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
    Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
    Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
    Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
    Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review.
    Nobusawa S; Nakata S; Yoshida Y; Yamazaki T; Ueki K; Amano K; Yamamoto J; Miyahara M; Sugai T; Nakazato Y; Hirato J; Yokoo H
    Virchows Arch; 2020 May; 476(5):763-772. PubMed ID: 31707588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.
    Judkins AR
    Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.